Experimental stem cell therapy a potential weapon against COVID-19
Excerpt from the Article:
When the COVID-19 pandemic hit, researchers in Canada and around the world moved quickly to pivot their research and help with the development of new treatments and vaccines.
At The Ottawa Hospital, this resulted in more than 60 different research projects and trials, including an innovative clinical trial of mesenchymal stem / stromal cells (MSCs) for severely ill COVID-19 patients.
Co-led by Drs. Duncan Stewart, Shane English, Dean Fergusson, the trial is designed to see if MSCs from the umbilical cord may be able to help the body’s immune system fight COVID-19 while reducing damage to vital organs. It builds on a previous clinical trial at The Ottawa Hospital in patients in severe septic shock – the first trial of its kind in the world.
Click the button below to read the entire Article:
Discover What Sets TrialStat Apart From Ordinary EDC Platforms
Click the image or button below to explore our eClinical Suite Platform and discover what sets TrialStat apart from competing EDC platforms.
Request Your Demo Today!
From rapid database build through database lock, we deliver consistent quality on-time and on-budget. Ready to upgrade your eClinical toolkit?